tiprankstipranks
Trending News
More News >
Herbalife Ltd (HLF)
NYSE:HLF
Advertisement

Herbalife (HLF) AI Stock Analysis

Compare
512 Followers

Top Page

HLF

Herbalife

(NYSE:HLF)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 4o)
Rating:56Neutral
Price Target:
$9.00
▲(16.13% Upside)
Herbalife's overall stock score reflects a mix of financial challenges and strategic advancements. The most significant factor is the company's financial performance, which is hindered by declining revenues and high leverage. While the valuation suggests the stock is undervalued, technical indicators show bearish momentum. The earnings call provided some positive insights, but ongoing sales declines and currency headwinds remain concerns.
Positive Factors
New Product Launches
The introduction of new products like MultiBurn and a healthy lifespan supplement can enhance Herbalife's market presence and drive long-term growth by expanding its product portfolio and attracting new customers.
Debt Reduction
Reducing debt improves financial stability and lowers interest expenses, enhancing Herbalife's ability to invest in growth initiatives and withstand economic fluctuations over time.
North America Volume Growth
Achieving volume growth in North America signals potential recovery and market strength, indicating successful strategies that could be replicated in other regions for sustained growth.
Negative Factors
Declining Revenue
Continued revenue decline suggests challenges in maintaining market share and consumer demand, which could impact long-term growth prospects unless addressed with strategic initiatives.
High Financial Leverage
High leverage and negative equity position pose risks to financial stability, limiting Herbalife's ability to invest in growth and respond to market changes, impacting long-term viability.
Currency Headwinds
Currency headwinds can erode international sales and profitability, creating ongoing challenges in managing global operations and impacting financial performance over the medium term.

Herbalife (HLF) vs. SPDR S&P 500 ETF (SPY)

Herbalife Business Overview & Revenue Model

Company DescriptionHerbalife Nutrition Ltd. is a global nutrition company that sells dietary supplements and personal care products. Founded in 1980, Herbalife operates in the health and wellness sector, focusing on weight management, nutrition, and personal care. The company offers a range of products including protein shakes, vitamins, herbal teas, and skincare items, all aimed at promoting a healthy lifestyle. Herbalife primarily markets its products through a multi-level marketing (MLM) model, utilizing a network of independent distributors to reach consumers worldwide.
How the Company Makes MoneyHerbalife generates revenue primarily through the sale of its products, which are distributed by independent distributors who earn commissions based on their sales and the sales of their recruits. This MLM structure creates multiple revenue streams: direct sales to consumers, commissions from distributor sales, and bonuses for distributors based on their sales performance and team sales. Additionally, Herbalife benefits from retail sales through its branded stores and online platforms. The company's earnings are also influenced by promotional partnerships and sponsorships within the fitness and wellness industries, reinforcing its brand presence and driving product demand.

Herbalife Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Neutral
The earnings call reflected a mix of strategic advancements and financial challenges. While the launch of new platforms and products, as well as operational efficiencies, were positive, the continued decline in net sales and volume, influenced by currency headwinds, presented challenges. The company is showing signs of recovery and growth, particularly in North America.
Q2-2025 Updates
Positive Updates
Launch of Pro2col Platform
Herbalife launched the beta version of the Pro2col platform, with over 7,000 distributors participating. This represents a significant step towards personalized, data-driven wellness solutions.
Introduction of New Products
New product launches included MultiBurn, a nonpharmaceutical weight loss supplement, and a healthy lifespan supplement. These products are expected to enhance the company's market presence.
Adjusted EBITDA Exceeds Guidance
Q2 adjusted EBITDA was $174 million, exceeding the high end of the guidance range, showcasing operational efficiency.
Debt Reduction
Herbalife paid down $55 million in debt during the quarter, maintaining a leverage ratio of 3x.
North America Volume Growth
July marked the first month of year-over-year volume growth in North America since April 2021, indicating positive regional momentum.
Negative Updates
Decline in Overall Net Sales
Net sales for Q2 were $1.3 billion, down 1.7% compared to Q2 of 2024, despite being within the guidance range.
Currency Headwinds
Unfavorable foreign exchange movements negatively impacted sales by approximately 170 basis points year-over-year.
Volume Decline in Key Markets
Volume was down 3.1% year-over-year, with notable declines in North America (6%) and China (6%).
Company Guidance
During the Herbalife Second Quarter 2025 Earnings Conference Call, the company provided updated guidance, highlighting several key metrics. Net sales for Q2 were reported at $1.3 billion, down 1.7% from Q2 2024, but flat on a constant currency basis. Despite this, the company achieved a solid adjusted EBITDA of $174 million, exceeding guidance, with an adjusted EBITDA margin of 13.8%. Herbalife also paid down $55 million in debt, maintaining a total leverage ratio of 3x as of June 30. The company noted a milestone in North America with year-over-year volume growth in July for the first time since April 2021. As a result of this progress, Herbalife raised and narrowed its full-year net sales guidance range. For Q3, net sales growth is projected to be between 0.5% and 4.5%. The call also emphasized the ongoing transformation into a data-driven wellness company, with the launch of the Pro2col app in North America, and the introduction of new products like MultiBurn and a healthy lifespan supplement.

Herbalife Financial Statement Overview

Summary
Herbalife's financial performance is mixed. Strong gross profit margins indicate efficient cost management, but declining revenue and net profit margins highlight challenges in sustaining growth. The balance sheet shows significant financial leverage and negative equity, posing risks to financial stability. Cash flow generation is stable, but high financing outflows suggest potential liquidity pressures.
Income Statement
65
Positive
Herbalife's income statement shows a declining trend in total revenue over the past few years, with a recent TTM total revenue of $4.95 billion, down from $5.20 billion in 2022. The gross profit margin remains strong at approximately 77.39% for the TTM period, indicating efficient cost management. However, the net profit margin has decreased to 5.66% from higher levels in previous years, highlighting challenges in maintaining profitability. The EBIT margin for TTM stands at 9.08%, and EBITDA margin at 10.64%, both reflecting a stable yet pressured operating environment.
Balance Sheet
40
Negative
The balance sheet reveals significant financial leverage, with a negative stockholders' equity of -$736 million as of TTM, indicating high debt levels relative to assets. The debt-to-equity ratio is not calculable due to negative equity, raising concerns about financial stability. The equity ratio is also negative, further emphasizing the risk associated with high indebtedness. Despite these challenges, total assets remain substantial at $2.68 billion.
Cash Flow
55
Neutral
Herbalife's cash flow statement shows a modest free cash flow growth, with TTM free cash flow of $164.4 million, slightly higher than the previous year's $163.4 million. The operating cash flow to net income ratio is 0.97, indicating efficient cash conversion from net income. However, the high levels of financing cash outflows raise concerns about reliance on debt to fund operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.93B4.99B5.06B5.20B5.80B5.54B
Gross Profit3.85B3.89B3.87B4.03B4.56B4.39B
EBITDA620.10M509.10M482.20M672.70M854.60M740.90M
Net Income325.00M254.30M142.20M321.30M447.20M372.60M
Balance Sheet
Total Assets2.74B2.73B2.81B2.73B2.82B3.08B
Cash, Cash Equivalents and Short-Term Investments320.90M415.30M575.20M508.00M601.50M1.05B
Total Debt2.35B2.47B2.77B2.88B2.96B2.64B
Total Liabilities3.39B3.53B3.87B4.00B4.21B3.93B
Stockholders Equity-660.50M-801.10M-1.06B-1.27B-1.39B-856.10M
Cash Flow
Free Cash Flow171.40M163.40M222.50M196.10M308.90M516.60M
Operating Cash Flow265.30M285.40M357.50M352.50M460.30M628.60M
Investing Cash Flow-85.00M-84.60M-134.80M-156.20M-156.40M-123.20M
Financing Cash Flow-227.50M-335.30M-148.30M-264.70M-728.60M-320.90M

Herbalife Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.75
Price Trends
50DMA
8.98
Negative
100DMA
9.07
Negative
200DMA
8.14
Negative
Market Momentum
MACD
-0.27
Positive
RSI
36.55
Neutral
STOCH
12.49
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLF, the sentiment is Negative. The current price of 7.75 is below the 20-day moving average (MA) of 8.54, below the 50-day MA of 8.98, and below the 200-day MA of 8.14, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 36.55 is Neutral, neither overbought nor oversold. The STOCH value of 12.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HLF.

Herbalife Risk Analysis

Herbalife disclosed 34 risk factors in its most recent earnings report. Herbalife reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Herbalife Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$237.73M18.079.15%4.33%-6.33%
$1.78B13.988.70%-4.90%0.29%
$1.65B19.728.79%3.61%0.50%-4.46%
$1.95B19.235.86%8.98%-26.29%
$20.33B14.63-3.31%3.23%1.93%-12.26%
$386.45M23.763.20%5.88%-68.62%
$824.85M2.52-2.25%288.79%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLF
Herbalife
8.00
0.17
2.17%
CENT
Central Garden Pet
30.67
-4.08
-11.74%
JJSF
J & J Snack Foods
84.65
-77.08
-47.66%
SMPL
Simply Good Foods
19.57
-14.53
-42.61%
NATR
Nature's Sunshine Products
13.48
0.37
2.82%
USNA
USANA Health
21.15
-16.14
-43.28%

Herbalife Corporate Events

Herbalife Ltd’s Earnings Call: Innovation Amid Challenges
Aug 8, 2025

Herbalife Ltd’s recent earnings call painted a mixed picture, with a blend of optimism and challenges. The company celebrated significant product innovation and positive momentum in North America, driven by strong distributor engagement and financial performance that exceeded expectations. However, it also faced hurdles, including a decline in net sales and regional difficulties in EMEA and China.

Herbalife Ltd. Reports Strong Q2 Earnings and Raises Guidance
Aug 7, 2025

Herbalife Ltd., a global health and wellness company, specializes in nutrition products and offers a business opportunity for independent distributors across more than 90 markets.

Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements
Herbalife Reports Q2 2025 Financial Results and Innovations
Positive
Aug 6, 2025

Herbalife reported its financial results for the second quarter of 2025, with net sales of $1.3 billion, slightly down by 1.7% compared to the previous year, impacted by foreign currency headwinds. The company exceeded its adjusted EBITDA guidance and raised its full-year net sales and adjusted EBITDA outlook. Recent developments include the launch of MultiBurn, a new weight-loss supplement, and the unveiling of the beta version of the Pro2col app, indicating a focus on innovation and expanding product offerings. These initiatives, along with strong distributor engagement programs, are expected to drive future growth and enhance Herbalife’s market position.

The most recent analyst rating on (HLF) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Herbalife stock, see the HLF Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025